Solving the problem of antimicrobial resistance: Is a global approach necessary?

Drug Discovery Today

Volumn 8, Issue 1, 2003, Pages 1-2

  Coast, Joanna ^a   Smith, Richard D ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; COST BENEFIT ANALYSIS; DRUG USE; EDITORIAL; HUMAN; INFECTION; LAW; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; POLICY;

DRUG RESISTANCE, BACTERIAL; HEALTH POLICY; WORLD HEALTH;

EID: 0037252337     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02542-4     Document Type: Editorial

References (13)

1. Appelbaum P. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:1992;77-83.
2. The Path of Least Resistance. 1998;Department of Health, London.
3. Reacher M.H., et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br. Med. J. 320:2000;213-216.
4. Smith R.D., Coast J. Antimicrobial resistance: a global response. Bull. WHO. 80:2002;126-133.
5. Smith R.D., et al. Over-the-counter antimicrobials: the hidden costs of resistance. J. Antimicrob. Chemother. 37:1996;1031-1032.
6. Coast J., et al. Superbugs: should antimicrobial resistance be included as a cost in economic evaluation? Health Econ. 5:1996;217-226.
7. Coast J., et al. An economic perspective on policy to reduce antimicrobial resistance. Soc. Sci. Med. 46:1998;29-38.
8. Stiglitz J.E. Knowledge as a global public good. Kaul I., et al. Global Public Goods - International Cooperation in the 21st Century. 1999;308-325 Oxford University Press.
9. Thorsteinsdottir H., et al. Genomics and global public goods for health. Smith R.D., et al. Global Public Goods for Health. 2003;Oxford University Press.
10. Fidler D. Legal issues associated with antimicrobial drug resistance. Emerg. Infect. Dis. 4:1998;169-177.
11. Coast, J. et al. Superbugs II: How should economic evaluation be conducted for interventions which aim to reduce antimicrobial resistance? Health Econ. (in press).
12. Wilton P., et al. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. J. Health Serv. Res. Policy. 7:2002;111-117.
13. Global Strategy for the Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/2001.2. 2001;World Health Organisation, Geneva.